MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20040352

August 27, 2024

Drug Information

玻璃酸钠滴眼液

联邦亮晶晶

滴眼剂

(1)5ml:5mg (2)7ml:7mg

化学药品

August 27, 2024

Company Information

Applicant Company

广东省中山市坦洲镇嘉联路12号

Manufacturing Company

广东省中山市坦洲镇嘉联路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath